Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Vivos Therapeutics (VVOS)

Annual Return

Over the past 3 years, VVOS has had an average annual return of -59.79%, underperforming the benchmark SPY, which returned +22.45% annual.

Over the past 5 years, VVOS has had an average annual return of -65.32%, underperforming the benchmark SPY, which returned +13.88% annual.

Since Dec 11, 2020, VVOS has had an average annual return of -65.57%, underperforming the benchmark SPY, which returned +15.69% annual.

2026202520242023202220212020
-67.78%-52.88%-65.52%+23.94%-82.14%-61.93%-34.26%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-20.00%-13.89%-14.52%-32.08%-13.89%-6.45%-67.78%
2025-7.33%-12.99%-17.53%-0.79%-14.29%+30.56%+36.88%+0%-28.50%-16.67%-12.17%-10.89%-52.88%
2024-40.79%-21.04%-16.99%-47.44%-17.70%+6.45%+3.03%+18.63%-4.13%-3.45%+35.71%+25.66%-65.52%
2023+171.14%-43.98%-44.18%+1.06%+10.70%+33.73%-42.86%-13.58%-23.57%-33.18%+662.24%-49.17%+23.94%
2022+9.75%+35.24%-19.76%-35.46%+17.36%-36.45%-10.87%+6.96%-47.15%+10.79%-30.59%-19.60%-82.14%
2021+10.66%+14.83%-11.59%+4.67%-22.60%-7.99%-38.99%+74.19%-23.19%-10.15%-29.77%-11.74%-61.93%
2020-34.26%-34.26%

Drawdown analysis of Vivos Therapeutics (VVOS)

The maximum drawdown for the VVOS was -99.76%, occurring on May 19, 2026. This drawdown has not yet recovered.

The current VVOS drawdown is -99.73%.

Since Dec 11, 2020 VVOS has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 2 times
  • 20% or more: 3 times
  • 10% or more: 3 times
DepthStartTo BottomBottomTo RecoverEndTotal
-99.76%Apr 6, 20211286May 19, 2026OngoingOngoingOngoing
-35.12%Dec 17, 20209Dec 31, 202063Apr 5, 202172
-24.58%Dec 11, 20203Dec 16, 20201Dec 17, 20204